FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to urology, and can be used for treating and preventing benign prostatic hyperplasia (BPH). According to the invention, the methods comprise administering a derived peptide to amino acid sequence of SEQ ID NO:1.
EFFECT: use of the inventions allows effectively treating BPH by inhibiting factors inducing BPH, reducing expression levels of PCNA and Ki67.
11 cl, 5 tbl, 15 dwg, 5 ex
